Invention Grant
- Patent Title: Pyrimidine compounds for the treatment of hepatitis C
-
Application No.: US14771914Application Date: 2014-03-05
-
Publication No.: US09656992B2Publication Date: 2017-05-23
- Inventor: Tao Wang , Christopher Allard , Paul Michael Scola
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- International Application: PCT/US2014/020661 WO 20140305
- International Announcement: WO2014/138199 WO 20140912
- Main IPC: A61K45/06
- IPC: A61K45/06 ; A61K31/506 ; C07D401/12 ; C07D401/14 ; C07D417/14 ; C07D413/14 ; A61K31/5377
Abstract:
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Public/Granted literature
- US20160159769A1 Pyrimidine Compounds for the Treatment of Hepatitis C Public/Granted day:2016-06-09
Information query
